HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William E Delaney Selected Research

selgantolimod

1/2021Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B.
1/2020Discovery of GS-9688 (Selgantolimod) as a Potent and Selective Oral Toll-Like Receptor 8 Agonist for the Treatment of Chronic Hepatitis B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William E Delaney Research Topics

Disease

18Chronic Hepatitis B
01/2021 - 08/2002
16Infections
03/2020 - 08/2002
3Hepatitis B
07/2013 - 12/2003
2Viremia
03/2020 - 07/2005
2Persistent Infection
02/2012 - 06/2004
1Genetic Translocation (Chromosomal Translocation)
01/2021
1Hepatitis C
12/2014
1Coinfection
05/2007
1Body Weight (Weight, Body)
07/2005
1HIV Infections (HIV Infection)
07/2005

Drug/Important Bio-Agent (IBA)

8Antiviral Agents (Antivirals)IBA
01/2018 - 06/2004
7adefovir dipivoxil (Hepsera)FDA Link
05/2007 - 08/2002
5Pharmaceutical PreparationsIBA
01/2018 - 07/2005
5NucleotidesIBA
05/2013 - 01/2005
5NucleosidesIBA
05/2013 - 07/2003
4Lamivudine (Epivir)FDA Link
05/2007 - 11/2003
3GS-9256IBA
01/2017 - 02/2012
3adefovirIBA
05/2007 - 07/2003
2DNA (Deoxyribonucleic Acid)IBA
01/2021 - 12/2003
2selgantolimodIBA
01/2021 - 01/2020
2Toll-Like Receptor 8IBA
01/2021 - 01/2020
2vesatolimodIBA
01/2018 - 01/2018
2Toll-Like Receptor 7IBA
01/2018 - 01/2018
2InterferonsIBA
01/2017 - 05/2013
2GS-9451IBA
12/2014 - 01/2014
2Protease Inhibitors (Protease Inhibitor)IBA
01/2014 - 07/2009
2Hepatitis B e AntigensIBA
05/2007 - 01/2003
2ProTidesIBA
05/2007 - 01/2007
2Tenofovir (Viread)FDA Link
07/2006 - 07/2005
2Circular DNAIBA
06/2004 - 12/2003
1Peptides (Polypeptides)IBA
03/2020
1Taurocholic Acid (Sodium Taurocholate)IBA
03/2020
1hepatitis B virus X proteinIBA
01/2017
1CytokinesIBA
01/2017
1Peptide Hydrolases (Proteases)FDA Link
12/2014
1phosphonic acidIBA
07/2009
1Interferon-alpha (Interferon Alfa)IBA
05/2007
1ProdrugsIBA
07/2006
1Surface Antigens (Surface Antigen)IBA
07/2005
1AntigensIBA
07/2005
1Proteins (Proteins, Gene)FDA Link
01/2003
1Codon (Codons)IBA
01/2003

Therapy/Procedure

10Therapeutics
03/2020 - 08/2002
1Aftercare (After-Treatment)
05/2013
1Liver Transplantation
05/2007
1Oral Administration
07/2005